Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Pick the window you'll actually stick to day after day
(2022) demonstrated Cerebrolysin's effects on Alzheimer's disease biomarkers in a randomized controlled trial, providing objective biological evidence for its neurotrophic activity (PMID: 36155516) Regulatory Validation: Approved for clinical use in over 40 countries for indications including stroke, traumatic brain injury, and dementia (though not FDA-approved in the United States) Dihexa: Preclinical Only, with Integrity Concerns Dihexa's evidence base is entirely preclinical and has faced significant scientific integrity challenges: Foundational Research: Wright et al
01 Modulates 4,000+ genes (6% 02 70% improvement in skin 03 35% increase in procollagen Anti-Aging & Longevity GHK-Cu is a naturally occurring copper-binding tripeptide that declines with age
If you purchased DSIP months ago and stored it improperly, potency may have declined significantly
